利用组合型rAAV2衣壳突变载体经玻璃体腔递送提高小鼠和人视网膜光感受器靶向性
研究评估三种基于rAAV2/2的衣壳突变载体经玻璃体腔注射后在小鼠视网膜的光感受器转导效率,其中嵌合载体rAAV2/2[MAX]转导视网膜比例显著高于两种单一突变载体,并在人视网膜外植体中转导光感受器和神经节细胞。
要点
- 嵌合载体rAAV2/2[MAX]经玻璃体腔递送后在小鼠视网膜转导比例显著高于单一突变载体。
- rAAV2/2[MAX]可转导人光感受器和神经节细胞。
- 将互补作用机制的突变组合于单一载体可增强转导。
核心结论
- rAAV2/2[MAX]的转导结果表明,将具有互补作用机制的突变组合于单一载体可增强转导。
- rAAV2/2[MAX]能够转导人光感受器和神经节细胞,提示经玻璃体腔载体递送具有潜力。
研究设计与样本
- 研究将含GFP或mCherry报告基因的载体经玻璃体腔注射入C57BL/6J或Nrl-EGFP小鼠,并用定制多线共聚焦扫描激光检眼镜在体评估转导。
- 对注射的Nrl-EGFP小鼠视网膜采用流式细胞术定量转导的光感受器。
- 死后人视网膜组织在给予rAAV2/2[MAX]后培养,C57BL/6J视网膜和人外植体经冷冻切片确定载体嗜性。
主要发现
- 嵌合载体rAAV2/2[MAX]经玻璃体腔递送后在小鼠视网膜转导的视网膜比例显著高于任一单一突变血清型,包括内层视网膜细胞和光感受器。
- 载体rAAV2[MAX]显示可转导人光感受器和神经节细胞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Effective intravitreal gene delivery to cells of the central retina (i.e., photoreceptors) would be of substantial benefit for treating patients with retinal diseases, such as achromatopsia, where retinal detachment from a subretinal may be harmful. Previous studies demonstrated that mutation of the recombinant adeno-associated virus (rAAV) capsid through introduction of peptide insertions or amino acid substitutions dramatically alters vector tropism. Herein, we evaluate the photoreceptor transduction efficiency of three rAAV2/2-based capsid mutant vectors: rAAV2/2[7m8], rAAV2/2[QuadYF+TV], and a chimeric vector incorporating both mutations (termed rAAV2/2[MAX]) following intravitreal delivery in mice. Furthermore, we evaluate the transduction efficiency of rAAV2/2[MAX] using explanted human central retinal samples to address clinical translatability. METHODS: Vectors containing a GFP or mCherry reporter gene were intravitreally injected into C57BL/6J or Nrl-EGFP mice, respectively. Transduction was assessed in vivo utilizing a custom multiline confocal scanning laser ophthalmoscope. Injected Nrl-EGFP mouse retinas were used to quantify transduced photoreceptors using flow cytometry. Postmortem human retinal tissue was cultured following administration of rAAV2/2[MAX]. C57BL/6J retinas and human explants were cryosectioned to determine vector tropism. RESULTS: The chimeric vector rAAV2/2[MAX] transduced significantly higher proportions of the retina than did either single mutant serotypes following intravitreal delivery in murine retina, including inner retinal cells and photoreceptors. Vector rAAV2[MAX] demonstrated transduction of human photoreceptors and ganglion cells. CONCLUSIONS: Transduction observed via rAAV2/2[MAX] indicates that combining mutations with complementary mechanisms of action in a single vector results in enhanced transduction. rAAV2/2[MAX] also presented the ability to transduce human photoreceptors and ganglion cells, indicating potential for efficient intravitreal vector delivery.
引用
- Reid CA, Ertel KJ, Lipinski DM, et al. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors. Invest Ophthalmol Vis Sci. 2017. PMID: 29260200. doi:10.1167/iovs.17-22281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。